Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4835825
Reference Type
Journal Article
Subtype
Review
Title
Clinical considerations for an effective medical therapy in Wilson's disease
Author(s)
Weiss, KH; Stremmel, W
Year
2014
Is Peer Reviewed?
Yes
Journal
Annals of the New York Academy of Sciences
ISSN:
0077-8923
EISSN:
1749-6632
Volume
1315
Page Numbers
81-85
Language
English
PMID
24754532
DOI
10.1111/nyas.12437
Abstract
Wilson's disease is an autosomal recessively inherited copper overload disorder that leads to hepatic and/or neurologic symptoms. More than a century after the first description of Wilson's disease, the available medical treatment options have not been standardized. The efficacy of the commonly used drugs is satisfactory for hepatic disease, but disappointing in the neurologic patients, including the risk of neurologic deterioration after the initiation of chelation therapy. An approach to overcome this problem is the careful and systematic assessment of biochemical response patterns and the quantitative monitoring of symptoms using validated rating scales. Standardized dosage strategies that address changes in copper pools might improve adherence and reduce side effects. Such an approach may reduce long-term morbidity. In this paper, we discuss considerations for an effective medical treatment and requirements for future studies in Wilson's disease.
Tags
IRIS
•
Molybdenum
Litsearch 2018
Pubmed
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity